# Oral fluorouracil vs vinorelbine plus cisplatin as adjuvant chemotherapy for stage II‐IIIA non‐small cell lung cancer: Propensity score‐matched and instrumental variable analyses

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/oral-fluorouracil-vs-vinorelbine-plus-cisplatin-as-adjuvant-chemotherapy-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hirokazu Urushiyama,Taisuke Jo,Hideo Yasunaga,Nobuaki Michihata,Hiroki Matsui,Wakae Hasegawa,Hideyuki Takeshima,Yukiyo Sakamoto,Yoshihisa Hiraishi,Akihisa Mitani,Kiyohide Fushimi,Takahide Nagase,Yasuhiro Yamauchi |
| Citations | 9 |
| DOI | 10.1002/cam4.1725 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.1725 |
| OpenAlex ID | https://openalex.org/W2888782841 |
| PMID | 30151905 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Yoshihisa Hiraishi](https://scholariq.org/researchers/yoshihisa-hiraishi/)

## Paper journal

- [Cancer Medicine](https://scholariq.org/journals/cancer-medicine/)

## Paper primary topic

- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

## Paper topics

- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.